Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05554081 · ClinicalTrials.gov registry record · NA
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
A NA study of Urinary Tract Infections and Asymptomatic Bacteriuria, sponsored by Loyola University.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05554081: Active NA study of Urinary Tract Infections and Asymptomatic Bacteriuria, sponsored by Loyola University.
NCT05554081 is a NA study of Urinary Tract Infections and Asymptomatic Bacteriuria that is active but no longer recruiting, run by Loyola University. The registered enrollment target is 200 participants, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05554081, a NA study of Urinary Tract Infections and Asymptomatic Bacteriuria, is active but no longer recruiting, sponsored by Loyola University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims specifically to compare the rates of contaminants between standard clean-catch urine collection and urine collected using the PEEZY device. In particular, this study will compare the rates of contamination as stratified by BMI status (i.e., BMI \< 30 and BMI ≥30). Based on previous studies through LUHS and the Wolfe lab, we anticipate a reduction in contamination from sample collected using the PEEZY device, particularly among those pregnant women with BMI ≥30. To investigate this hypothesis we have designed a prospective unblinded randomized controlled trial comparing voided urine specimens obtained for asymptomatic bacteriuria in pregnant women presenting for obstetric care with use of standard clean-catch (CC) sampling method versus specimen obtained using PEEZY collection device.
Primary Outcome
1\. To compare the rates of contaminants between CC and PEEZY samples stratified by BMI status (i.e., BMI \< 30 and BMI ≥30)
Conditions Studied
Interventions
- DEVICE Peezy urine collection device
Study Locations (1)
Illinois
- Loyola University medical Center - Maywood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2024-10-31 |
| Phase | NA |
What the registry record for NCT05554081 still lists
NCT05554081 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which Peezy urine collection device is the first listed.
NCT05554081 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05554081 about?
NCT05554081 is a clinical study titled "Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB". This study aims specifically to compare the rates of contaminants between standard clean-catch urine collection and urine collected using the PEEZY device. In particular, this study will compare the rates of contamination as stratified by BMI status (i.e., BMI \< 30 and BMI ≥30). Based on previous s...
What is the current status of trial NCT05554081?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-08-01. Estimated completion is 2024-10-31.
What conditions does trial NCT05554081 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Asymptomatic Bacteriuria.
What interventions are being tested in trial NCT05554081?
The interventions under investigation include: Peezy urine collection device (DEVICE).
Who is sponsoring clinical trial NCT05554081?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05554081 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05554081's enrollment target sits among peer trials
200 17th of 34 higher than 18 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
-
Dissemination and Implementation of a Videoconference Antimicrobial Stewardship Team
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI